{"nct_id":"NCT06995430","title":"A Phase 3 Study to Assess the Immune Response And Safety Of Rmenb+Omv Nz In Primed Healthy Participants (10 To 20 Years Old)","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2025-07-07","start_date_type":"ACTUAL","primary_completion_date":"2025-12-10","primary_completion_date_type":"ESTIMATED","completion_date":"2025-12-10","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GSK"]}